The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Wallace Steven P. | President, Adv. Surgery | Tax withholding(F) | 153 | $18.68 | $3K |
| Jun 2, 2026 | Teaff James | President, CCS | Tax withholding(F) | 321 | $18.68 | $6K |
| Jun 1, 2026 | Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Wilkes David S. | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Wendell Amy McBride | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Schlichting Nancy M | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Morrison Patricia | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | McDonnell Michael R. | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Ampofo William A. II | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Craig Jeffrey A | Director | Grant(A) | 13K | — | $0 |
| May 5, 2026 | Shafer David Brent | Director | Grant(A) | 13K | — | $0 |
| Mar 6, 2026 | Grade Joel T. | EVP and CFO | Tax withholding(F) | 8K | $17.69 | $144K |
| Mar 6, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 13K | $17.69 | $224K |
| Mar 6, 2026 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 7K | $17.69 | $117K |
| Mar 6, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Tax withholding(F) | 3K | $17.69 | $50K |
| Mar 6, 2026 | Zielinski Anita A | SVP, CAO and Controller | Tax withholding(F) | 2K | $17.69 | $34K |
| Mar 2, 2026 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 1K | $19.69 | $26K |
| Mar 2, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Tax withholding(F) | 2K | $19.69 | $36K |
| Mar 2, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 2K | $19.69 | $32K |
| Feb 27, 2026 | Zielinski Anita A | SVP, CAO and Controller | Grant(A) | 31K | — | $0 |
| Feb 27, 2026 | Grade Joel T. | EVP and CFO | Grant(A) | 43K | — | $0 |
| Feb 27, 2026 | Grade Joel T. | EVP and CFO | Grant(A) | 103K | — | $0 |
| Feb 27, 2026 | Rosenbloom David S. | EVP and General Counsel | Grant(A) | 27K | — | $0 |
| Feb 27, 2026 | Rosenbloom David S. | EVP and General Counsel | Grant(A) | 65K | — | $0 |
| Feb 27, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant(A) | 24K | — | $0 |
| Feb 27, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant(A) | 57K | — | $0 |
| Feb 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | Grant(A) | 18K | — | $0 |
| Feb 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | Grant(A) | 12K | — | $0 |
| Feb 27, 2026 | Carlisle Cynthia | Executive Vice President, CHRO | Grant(A) | 43K | — | $0 |
| Feb 27, 2026 | Hider Andrew P. | President and CEO, Director | Grant(A) | 202K | — | $0 |
| Feb 27, 2026 | Hider Andrew P. | President and CEO, Director | Grant(A) | 489K | — | $0 |
| Feb 13, 2026 | McDonnell Michael R. | Director | Grant(A) | 2K | — | $0 |
| Feb 9, 2026 | Grade Joel T. | EVP and CFO | Tax withholding(F) | 9K | $21.73 | $199K |
| Feb 9, 2026 | Grade Joel T. | EVP and CFO | Grant(A) | 31K | — | $0 |
| Feb 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant(A) | 19K | — | $0 |
| Feb 9, 2026 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 6K | $21.73 | $125K |
| Feb 9, 2026 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 5K | $21.73 | $114K |
| Feb 9, 2026 | Rosenbloom David S. | EVP and General Counsel | Grant(A) | 17K | — | $0 |
| Feb 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Grant(A) | 2K | — | $0 |
| Feb 9, 2026 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | Tax withholding(F) | 918 | $21.73 | $20K |
| Dec 12, 2025 | Mason Jeanne K | EVP, Chief HR Officer | Tax withholding(F) | 650 | $19.15 | $12K |
| Dec 1, 2025 | Grade Joel T. | EVP and CFO | Tax withholding(F) | 8K | $19.08 | $158K |
| Sep 2, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | Tax withholding(F) | 2K | $24.17 | $45K |
| Sep 2, 2025 | Grade Joel T. | EVP and CFO | Grant(A) | 103K | — | $0 |
| Sep 2, 2025 | Hider Andrew P. | President and CEO, Director | Grant(A) | 236K | — | $0 |
| Sep 2, 2025 | Hider Andrew P. | President and CEO, Director | Grant(A) | 132K | — | $0 |
| Sep 2, 2025 | Hider Andrew P. | President and CEO, Director | Grant(A) | 466K | — | $0 |
| Sep 2, 2025 | Sonig Alok | EVP,Group President,Pharma | Tax withholding(F) | 3K | $24.17 | $77K |
| Aug 19, 2025 | Shafer David Brent | Director | Tax withholding(F) | 31K | $24.33 | $762K |
| Jun 2, 2025 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 17K | $29.55 | $489K |
| May 6, 2025 | Ampofo William A. II | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Morrison Patricia | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Oesterle Stephen N. | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Rusckowski Stephen H | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Schlichting Nancy M | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Smith Cathy R | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Wendell Amy McBride | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Wilkes David S. | Director | Grant(A) | 7K | — | $0 |
| May 6, 2025 | Craig Jeffrey A | Director | Grant(A) | 7K | — | $0 |
| Mar 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | Tax withholding(F) | 3K | $35.44 | $116K |
| Mar 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | Grant(A) | 10K | — | $0 |
| Mar 6, 2025 | Borzi James W | EVP,Chief Supply Chain Officer | Grant(A) | 33K | — | $0 |
| Mar 6, 2025 | Grade Joel T. | EVP and CFO | Tax withholding(F) | 4K | $35.44 | $153K |
| Mar 6, 2025 | Grade Joel T. | EVP and CFO | Grant(A) | 30K | — | $0 |
| Mar 6, 2025 | Grade Joel T. | EVP and CFO | Grant(A) | 98K | — | $0 |
| Mar 6, 2025 | Knight Heather | EVP, Chief Operating Officer | Tax withholding(F) | 14K | $35.44 | $483K |
| Mar 6, 2025 | Knight Heather | EVP, Chief Operating Officer | Grant(A) | 36K | — | $0 |
| Mar 6, 2025 | Knight Heather | EVP, Chief Operating Officer | Grant(A) | 119K | — | $0 |
| Mar 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | Grant(A) | 16K | — | $0 |
| Mar 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | Tax withholding(F) | 4K | $35.44 | $155K |
| Mar 6, 2025 | Mason Jeanne K | EVP, Chief HR Officer | Grant(A) | 52K | — | $0 |
| Mar 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant(A) | 26K | — | $0 |
| Mar 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 9K | $35.44 | $331K |
| Mar 6, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | Grant(A) | 87K | — | $0 |
| Mar 6, 2025 | Rosenbloom David S. | EVP and General Counsel | Grant(A) | 18K | — | $0 |
| Mar 6, 2025 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 5K | $35.44 | $174K |
| Mar 6, 2025 | Rosenbloom David S. | EVP and General Counsel | Grant(A) | 59K | — | $0 |
| Mar 6, 2025 | Sonig Alok | EVP,Group President,Pharma | Tax withholding(F) | 11K | $35.44 | $384K |
| Mar 6, 2025 | Sonig Alok | EVP,Group President,Pharma | Grant(A) | 30K | — | $0 |
| Mar 6, 2025 | Sonig Alok | EVP,Group President,Pharma | Grant(A) | 100K | — | $0 |
| Mar 6, 2025 | Zielinski Anita A | SVP, CAO and Controller | Grant(A) | 17K | — | $0 |
| Mar 3, 2025 | Borzi James W | EVP,Chief Suppy Chain Officer | Tax withholding(F) | 1K | $34.86 | $47K |
| Mar 3, 2025 | Knight Heather | EVP, Chief Operating Officer | Tax withholding(F) | 3K | $34.86 | $117K |
| Mar 3, 2025 | Mason Jeanne K | EVP, Chief HR Officer | Tax withholding(F) | 1K | $34.86 | $52K |
| Mar 3, 2025 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 2K | $34.86 | $69K |
| Mar 3, 2025 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 1K | $34.86 | $46K |
| Mar 3, 2025 | Sonig Alok | EVP,Group President,Pharma | Tax withholding(F) | 2K | $34.86 | $67K |
| Feb 5, 2025 | Shafer David Brent | Interim CEO and Chair, Director | Grant(A) | 76K | — | $0 |
| Jan 31, 2025 | Toth Christopher A. | EVP, Group Pres, Kidney Care | Tax withholding(F) | 25K | $32.56 | $826K |
| Dec 31, 2024 | Toth Christopher A. | EVP,Group Pres, Kidney Care | Tax withholding(F) | 33K | $29.16 | $951K |
| Dec 13, 2024 | Almeida Jose E | Chairman, CEO, President | Tax withholding(F) | 6K | $30.32 | $181K |
| Dec 2, 2024 | Grade Joel T. | EVP and CFO | Tax withholding(F) | 7K | $33.55 | $222K |
| Dec 2, 2024 | Knight Heather | EVP, Group Pres, Med Products | Tax withholding(F) | 6K | $33.55 | $203K |
| Dec 2, 2024 | Rasul Reazur | EVP,Group Pres,Healthcare | Tax withholding(F) | 2K | $33.55 | $68K |
| Sep 9, 2024 | Craig Jeffrey A | Director | Grant(A) | 3K | — | $0 |
| Sep 3, 2024 | Borzi James W | EVP,Chief Supply Chain Officer | Tax withholding(F) | 2K | $37.85 | $64K |
| Sep 3, 2024 | Sonig Alok | EVP,Group President, Pharma | Tax withholding(F) | 3K | $37.85 | $116K |
| Jun 3, 2024 | Rosenbloom David S. | EVP and General Counsel | Tax withholding(F) | 784 | $34.08 | $27K |
| Jun 3, 2024 | Toth Christopher A. | EVP,Group Pres, Kidney Care | Tax withholding(F) | 15K | $34.08 | $518K |
| May 7, 2024 | Ampofo William A. II | Director | Grant(A) | 6K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).